Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sunshine Website Goes Live With Some Context Sought By Industry

This article was originally published in The Pink Sheet Daily

Executive Summary

CMS releases data on $3.5 billion worth of payments made by drug and device companies to physicians and teaching hospitals in the last five months of 2013; an additional 199,000 payment records were not disclosed.

You may also be interested in...



Saudi FDA Wants Device & Drug Firms To Report Payments To Doctors, Health Institutions

The Saudi Food and Drug Authority has finalized the details of a new transparency initiative under which medical device and pharmaceutical companies will have to disclose their financial relationships with health-care professionals and institutions. 

Saudi FDA Wants Drug & Device Firms To Report Payments To Doctors, Health Institutions

The Saudi Food and Drug Authority has finalized the details of a new transparency initiative under which drug and medical device companies will have to disclose their financial relationships with healthcare professionals and institutions. 

GSK's Physician Communications Shifts To Internal Experts, Remote Formats

New global approach means that GlaxoSmithKline no longer will pay outside health care professionals to speak on firms' behalf.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS077735

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel